Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (2): 116-118.
• Contents • Previous Articles Next Articles
HU Ping
Received:
2017-03-10
Revised:
2017-03-10
Online:
2017-02-20
Published:
2017-03-10
CLC Number:
HU Ping. Relationship between the Incidence of Adverse Reactions and Injection Mode on Patients First Given Low Molecular Weight Heparin[J]. Chinese Journal of Pharmacovigilance, 2017, 14(2): 116-118.
[1] 刘璠, 封辰叶, 刘廷威,等. 低分子肝素单药抗凝治疗癌症相关急性肺血栓栓塞症疗效和预后分析[J]. 中国全科医学, 2014, 17(4):422-424.. [2] 张菊霞, 韩琳, 温玉洁,等. 皮下注射低分子肝素时不同推注时间对皮下出血的影响[J]. 中华护理杂志, 2014, 49(2):233-235. [3] 赵滨, 李艳玲, 王立芹,等. 低分子肝素皮下注射时间和按压时间对不良反应的影响研究[J]. 中国全科医学, 2016, 19(9):1037-1041. [4] 李春蕊, 张雯, 樊碧发. 数字评分法(NRS)与口述评分法(VRS)在老年慢性疼痛患者中的比较[J]. 中国疼痛医学杂志, 2016, 22(9):683-686. [5] 高晓津, 杨进刚, 杨跃进,等. 中国急性心肌梗死患者心血管危险因素分析[J]. 中国循环杂志, 2015, 30(3):206-210. [6] 黎雪玲, 李醒三. 急性心肌梗死患者先用低分子肝素对溶栓效果的影响[J]. 中国老年学杂志, 2016, 36(10):687. [7] Pourghaznein T, Azimi A V, Jafarabadi M A. The effect of injection duration and injection site on pain and bruising of subcutaneous injection of heparin[J]. J Clin Nurs,2014, 23(7/8):1105-1113. [8] 李艳玲, 赵滨, 沙莎,等. 低分子肝素皮下注射持续时间的循证护理效果观察[J]. 中国全科医学, 2014, 17(21):2483-2485. [9] 李香花. 改良注射方法在减少注射低分子肝素钠引起皮下出血和疼痛中的效果观察[J]. 护理实践与研究, 2015, 12(9):110-111. [10] Balci Akpinar R, Celcbioglu A. Effect of injection duration on bruising associated with wubcutaneous heparin: a quasi-experimental within-subject design[J]. Clin Nurs Stud, 2013,1(4):36-44. [11] 李艳玲, 赵滨, 刘慧敏. 低分子肝素皮下注射持续时间对不良反应影响的Meta分析[J]. 中国实用护理杂志, 2014, 30(18): 59-62. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||